Showing results (41-50 of 236) with videos related to
Sort By:
Pageof 24
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.Thorax|January 15, 2018
Airflow limitation in people living with HIV and matched uninfected controlsAndreas Ronit, Jens Lundgren, Shoaib Afzal, et al.Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.The Lancet. HIV|January 15, 2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 6, 2014
Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART studyLars Peters, Jacqueline Neuhaus, Daniel Duprez, et al.AIDS (London, England)|November 15, 2005
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?Amanda Mocroft, Vincent Soriano, Jurgen Rockstroh, et al.Scandinavian Journal of Infectious Diseases|July 9, 2008
Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cARTDaria Podlekareva, Amanda Mocroft, Ole Kirk, et al.AIDS (London, England)|May 13, 2006
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremiaAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.AIDS (London, England)|August 2, 2003
Virological rebound after suppression on highly active antiretroviral therapyAmanda Mocroft, Lidia Ruiz, Peter Reiss, et al.AIDS (London, England)|December 4, 2008
Interruption of antiretroviral therapy is associated with increased plasma cystatin CAmanda Mocroft, Christina Wyatt, Lynda Szczech, et al.Pageof 24